Cargando…

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive

The levonorgestrel intrauterine system (LNG IUS) has major advantages and could be a “game-changer” in improving contraceptive choice and use. It faces important challenges, however, including: (1) high commodity cost; (2) often-strong provider resistance to IUDs and difficult programmatic requireme...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobstein, Roy, Shelton, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682580/
https://www.ncbi.nlm.nih.gov/pubmed/26681702
http://dx.doi.org/10.9745/GHSP-D-15-00330
_version_ 1782405910714384384
author Jacobstein, Roy
Shelton, James D
author_facet Jacobstein, Roy
Shelton, James D
author_sort Jacobstein, Roy
collection PubMed
description The levonorgestrel intrauterine system (LNG IUS) has major advantages and could be a “game-changer” in improving contraceptive choice and use. It faces important challenges, however, including: (1) high commodity cost; (2) often-strong provider resistance to IUDs and difficult programmatic requirements; (3) need for demand creation, including assessing if markedly reduced menstrual bleeding is attractive to clients; and (4) the many requirements for introducing any new contraceptive. A good next step would be a well-focused and multifaceted “learning introduction” to assess the LNG IUS’s potential in several low-income countries, with rapid scale-up if results are promising.
format Online
Article
Text
id pubmed-4682580
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-46825802016-01-15 The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive Jacobstein, Roy Shelton, James D Glob Health Sci Pract Viewpoint The levonorgestrel intrauterine system (LNG IUS) has major advantages and could be a “game-changer” in improving contraceptive choice and use. It faces important challenges, however, including: (1) high commodity cost; (2) often-strong provider resistance to IUDs and difficult programmatic requirements; (3) need for demand creation, including assessing if markedly reduced menstrual bleeding is attractive to clients; and (4) the many requirements for introducing any new contraceptive. A good next step would be a well-focused and multifaceted “learning introduction” to assess the LNG IUS’s potential in several low-income countries, with rapid scale-up if results are promising. Global Health: Science and Practice 2015-12-15 /pmc/articles/PMC4682580/ /pubmed/26681702 http://dx.doi.org/10.9745/GHSP-D-15-00330 Text en © Jacobstein and Shelton. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: http://dx.doi.org/10.9745/GHSP-D-15-00330.
spellingShingle Viewpoint
Jacobstein, Roy
Shelton, James D
The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title_full The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title_fullStr The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title_full_unstemmed The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title_short The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
title_sort levonorgestrel intrauterine system: a pragmatic view of an excellent contraceptive
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682580/
https://www.ncbi.nlm.nih.gov/pubmed/26681702
http://dx.doi.org/10.9745/GHSP-D-15-00330
work_keys_str_mv AT jacobsteinroy thelevonorgestrelintrauterinesystemapragmaticviewofanexcellentcontraceptive
AT sheltonjamesd thelevonorgestrelintrauterinesystemapragmaticviewofanexcellentcontraceptive
AT jacobsteinroy levonorgestrelintrauterinesystemapragmaticviewofanexcellentcontraceptive
AT sheltonjamesd levonorgestrelintrauterinesystemapragmaticviewofanexcellentcontraceptive